Are we getting nearer to screening for atherosclerosis?

Circulation

Volumn 117, Issue 1, 2008, Pages 122-126

  Stern, Shlomo ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Medical Bldg ^*  (Israel)

Author keywords

Cardiovascular diseases; Prevention; Screening

Indexed keywords

CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ANKLE FRACTURE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BALLOON DILATATION; CASE REPORT; CORONARY ARTERY CALCIUM TEST; DIAGNOSTIC PROCEDURE; ECONOMICS; ELECTROCARDIOGRAM; FUNCTION TEST; HEALTH CARE COST; HEART ARREST; HOSPITAL; HUMAN; ISCHEMIC HEART DISEASE; MALE; MORTALITY; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RECREATION; SCREENING; SKIING; ST SEGMENT DEPRESSION;

ATHEROSCLEROSIS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 37349042535     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.702381     Document Type: Article

References (51)

1. Goff DC, Brass L, Braun LT, Croft JB, Flesch JD, Fowkes FGR, Hong Y, Howard V, Huston S, Jencks SF, Jencks SF, Luepker R, Manolio T, O'Donnell C, Robertson RM, Rosamond W, Rumsfield J, Sidney S, Zheng ZJ. Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease. Circulation. 2007;115:127-155.
2. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes, part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006;114:2850-2870.
3. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA. 2005;293:1245-1256.
4. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality on men: a randomized controlled trial. Lancet. 2002;360:1531-1539.
5. Smith SC Jr, Amsterdam E, Balady GJ, Bonow WO, Fletcher GF, Froelicher V, Heath G, Limacher MC, Maddahi J, Pryor D, Redberg RF, Roccella E, Ryan T, Smaha L, Wenger NK. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia. Circulation. 2000;101:e12-e15.
6. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Sanjay K, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Raymond B, Koenig W, Demirovic J, Arking D, Herrera VLM, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK, for the SHAPE Task Force. From vulnerable plaque to vulnerable patient, part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report. Am J Cardiol. 2006;98(suppl):2H-15H.
7. Fuster V. Foreword. Am J Cardiol. 2006;98(suppl):1H.
8. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D, for the Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601-1610.
9. Leal J, Luengo-Fernandez R, Gray A, Peterson S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610-1619.
10. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.
11. Stern S. Electrocardiogram: still the cardiologist's best friend. Circulation. 2006;113:e753-e756.
12. Rautharju PM, Ge S, Nelson JC, Marino Larsen EK, Psaty BM, Furberg CD, Zhang ZM, Robbins J, Gottdiener JS, Chaves PHM. Comparison of mortality risk for electrocardiographic abnormalities in men and women with and without coronary heart disease (from the Cardiovascular Health Study). Am J Cardiol. 2006;97:309-315.
13. Froelicher VF, Marcus R, Heidenreich PA. Prognostic value of computer electrocardiography in veteran outpatients: in patient populations with increased cardiovascular risk, is routine screening for electrocardiographic abnormalities worthwhile? Federal Practitioner. 2004;March:11-20.
14. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol. 2004;43:565-571.
15. Gaita F, Giusetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richiardi E, Borggrefe M. Short QT syndrome: a familial cause of sudden death. Circulation. 2003;108:965-970.
16. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schutlze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference. Circulation. 2005;111:659-670.
17. Massing MW, Simpson RJ Jr, Rautaharju PM, Schreiner PJ, Crow R, Heiss G. Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk in Communities Cohort). Am J Cardiol. 2006;98:1609-1612.
18. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Fredriksen BS, Davanlou M, Hansen, JF. Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age ≥55 years. Am J Cardiol. 2006;97:1352-1357.
19. Quaglini S, Rognoni, Spazzolini C, Priori SG, Mannarino S, Schwartz PJ. Cost effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J. 2006;27:1824-1832.
20. Van Hare GF, Perry J, Berul C, Triedman JK. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J. 2007;28:137.
21. Schwartz PJ, Quaglini S. Letter to the Editor. Eur Heart J. 2007;28:137-139.
22. Sox HC Jr, Garber AM, Littenberg B. The resting electrocardiogram as a screening test: a clinical analysis. Ann Intern Med. 1980;111:480-502.
23. Smith SC Jr, Amsterdam E, Balady GJ, Bonow WO, Fletcher GF, Froelicher V, Heath G, Limacher MC, Maddahi J, Pryor D, Redberg RF, Roccella E, Ryan T, Smaha L, Wenger NK. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia. Circulation. 2000;101:e12-e15.
24. Lauer M, Sivarajan Froelicher E, Williams M, Kligfield P. Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2005;112:771-776.
25. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
26. Iglesias del Sol A, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: relation to incident myocardial infarction: the Rotterdam Study. Eur Heart J. 2002;23:934-940.
27. Davis PH, Dawson JD, Riley AW, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation. 2001;104:2815-2819.
28. Lorenz MW , Markus,HS,Bots ML, Rosvall M Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
29. The Regence Group. The Regence Group Medical Policy Manual. Ultrasonic measurement of carotid intimal-medial thickness as an assessment of subclinical atherosclerosis. February 2007. Available at: http://www.regence.com/trgmedpol/ radiology/rad37.html. Accessed December 10, 2007.
30. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O'Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46:807-814.
31. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St Francis Heart Study. J Am Coll Cardiol. 2005;46:158-165.
32. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
33. Shaw LJ, Raggi P, Callister TQ, Berman DS. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J. 2006;27:968-975.
34. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007;115:402-426.
35. Bill would require heart-screening reimbursement. Houston Business Journal. February 14, 2007. Available at: http://houston.bizjournals.com/ houston/stories/2007/02/12/daily53.html. Accessed December 10, 2007.
36. Government: health care improves, but prevention remains missed opportunity. USA Today. January 11, 2007. Available at: http//www.usatoday.com/news/health/2007-01-11-prevention. Accessed December 10, 2007.
37. Cellermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474.
38. Napoli C, Lerman LO, de Nigris F, Gossl M, Balestrieri ML, Lerman A. Rethinking primary prevention of atherosclerosis-related diseases. Circulation. 2006;114:2517-2527.
39. Bonnetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168-175.
40. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.
41. Sattar N, Murray HM, McConnachie A. Blauw G, Bollen ELEM, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ Twomey C, Westendorp RGJ, Shepherd J, for the PROSPER Study Group C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation. 2007;115:981-989.
42. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P, for the Reversal of Atherosclerosis With Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary heart disease. N Engl J Med. 2005;352:29-38.
43. United States Preventive Services Task Force. Recommendation Statement: Screening for Peripheral Arterial Disease. Washington, DC: Agency for Healthcare Research and Quality; 2005:1-8.
44. Beckman JA, Jaff MR, Creager MA. The United States Preventive Services Task Force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation. 2006;114:861-866.
45. Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A, Liu PP. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol. 2006;48:1733-1741.
46. Feldman HA, Goldstein I, Hatzichristou D, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
47. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, Galli S, Ravagnani PM, Montorsi P. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003;44:360-365.
48. Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006;3:28-36.
49. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Salonia A, Deho F, Rigatti P, Montorsi F, Fiorentini C. Association between erectile dysfunction and coronary artery disease: role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J. 2006;27:2632-2639.
50. Jackson G. Erectile dysfunction: a marker of silent coronary artery disease. Eur Heart J. 2006;27:2613-2614.
51. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff. 2007;26:38-48.